Company Info
Phone(949) 481-0510
Year Established
1998
Ticker
GKOS
Exchange
NYSE
Contacts
Thomas BurnsChair & CEO
Chris M. Calcaterra
VP, Global Commercial Operations
Alex Thurman
CFO
Tomas Navratil, Ph.D.
CDO
Joseph Gilliam
President & COO
Jay L. Katz, MD, FACS
CMO
Company Description
Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.